dbACP: A Comprehensive Database of Anti-Cancer Peptides

8 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp03570 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay A-549 Lung cancer IC50 : > 83.6 µMo/L
dbacp03571 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay A-375 Skin cancer IC50 : > 83.6 µMo/L
dbacp03572 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay MCF-7 Breast cancer IC50 : > 83.6 µMo/L
dbacp03573 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay SW-1116 Colorectal cancer IC50 : > 83.6 µMo/L
dbacp03574 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay RD Rhabdomyosarcoma cancer IC50 : > 83.6 µMo/L
dbacp03575 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay H-1299 Lung cancer IC50 : 16.4 µMo/L
dbacp03576 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay B-16 Skin cancer IC50 : > 83.6 µMo/L
dbacp03577 L17A KWKSFLKTFKSAKKTVAHTALKAISS PeptideV13K Membrane disruption mechanism MTT/MTS assay HeLa Cervical cancer IC50 : > 83.6 µMo/L